Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;21(5):602-603.
doi: 10.1016/S1473-3099(21)00053-0. Epub 2021 Feb 15.

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran

Affiliations
Comment

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran

Mahan Ghafari et al. Lancet Infect Dis. 2021 May.
No abstract available

PubMed Disclaimer

Comment in

Comment on

  • SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H, Darvishian M, Mohammadi Z, Shayanrad A, Delavari A, Bahadorimonfared A, Eslami S, Javanmard SH, Shakiba E, Somi MH, Emami A, Saki N, Hormati A, Ansari-Moghaddam A, Saeedi M, Ghasemi-Kebria F, Mohebbi I, Mansour-Ghanaei F, Karami M, Sharifi H, Pourfarzi F, Veisi N, Ghadimi R, Eghtesad S, Niavarani A, Ali Asgari A, Sadeghi A, Sorouri M, Anushiravani A, Amani M, Kaveh S, Feizesani A, Tabarsi P, Keyvani H, Markarian M, Shafighian F, Sima A, Sadjadi A, Radmard AR, Mokdad AH, Sharafkhah M, Malekzadeh R. Poustchi H, et al. Lancet Infect Dis. 2021 Apr;21(4):473-481. doi: 10.1016/S1473-3099(20)30858-6. Epub 2020 Dec 15. Lancet Infect Dis. 2021. PMID: 33338441 Free PMC article.

References

    1. Ghafari M, et al. Ongoing outbreak of COVID-19 in Iran: challenges and signs of concern with under-reporting of prevalence and deaths. medRxiv. 2020 doi: 10.1101/2020.04.18.20070904. published online Aug 28. (preprint). - DOI
    1. Poustchi H, Darvishian M, Mohammadi Z, et al. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30858-6. published online Dec 15. - DOI - PMC - PubMed
    1. Ghafari M, Kadivar A, Katzourakis A. Excess deaths associated with the Iranian COVID-19 epidemic: a province-level analysis. medRxiv. 2020 doi: 10.1101/2020.12.07.20245621. published online Dec 8. (preprint). - DOI - PMC - PubMed

Uncited Reference

    1. Shakiba M, Nazemipour M, Salari A, et al. Seroprevalence of SARS-CoV-2 in Guilan province, Iran, April 2020. Emerg Infect Dis. 2020 doi: 10.3201/eid2702.201960. published online Dec 21. - DOI - PMC - PubMed

Substances